Clinical pharmacokinetics of atropine oral gel formulation in healthy volunteers.

"CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interests."

"FUNDING INFORMATION This research was supported by Primary Children Hospital Foundation (PCHF) Grant awarded to Venkata Kashyap Yellepeddi. The research reported in this publication was supported in part by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Numbers UL1TR002538 and UM1TR004409. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."

"The study protocol was reviewed and approved by the FDA under an investigator‐initiated investigational new drug (IND) application (IND #155751). The study protocol was also reviewed and approved by the Institutional Review Board (IRB), University of Utah (IRB #00144918). This study was a single‐center, open‐label, prospective PK trial conducted at the Utah Clinical and Translational Science Institute, Salt Lake City, Utah. The study was registered on clinicaltrials.gov (identifier: NCT05164367). "